This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.
Identification
- Generic Name
- Ox bile extract
- DrugBank Accession Number
- DB14016
- Background
Not Available
- Type
- Biotech
- Groups
- Approved, Experimental, Investigational
- Synonyms
- Beef bile
- Bos bovis bile
- Bos taurus bile
- Bovine bile
- Fel tauri
- Ox bile
- Purified oxgall
- Sodium choleate
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Associated Conditions
- Chronic Constipation
- Dyspepsia
- Gall Bladder Diseases
- Herpes Zoster
- Muscle Spasms
- Osteoarthritis (OA)
- Pancreatic Insufficiency
- Postoperative digestive insufficiency
- Prolonged Labour
- Sore Throat
- Digestion
- Gallstone formation
- Gastric acid deficiency
- Inflammatory disease of the pancreas
- Sinusitis following surgery or injury
- Associated Therapies
- Contraindications & Blackbox Warnings
Avoid life-threatening adverse drug eventsImprove clinical decision support with information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events & improve clinical decision support.- Pharmacodynamics
Not Available
- Mechanism of action
- Not Available
- Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates.Improve decision support & research outcomes with our structured adverse effects data.- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.
Drug Interaction Integrate drug-drug
interactions in your softwareAluminium phosphate The serum concentration of Ox bile extract can be decreased when it is combined with Aluminium phosphate. Aluminum chloride The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum chloride. Aluminum chlorohydrate The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum chlorohydrate. Aluminum hydroxide The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum hydroxide. Aluminum oxide The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum oxide. Aluminum sulfate The serum concentration of Ox bile extract can be decreased when it is combined with Aluminum sulfate. Bentonite The serum concentration of Ox bile extract can be decreased when it is combined with Bentonite. Bentoquatam The serum concentration of Ox bile extract can be decreased when it is combined with Bentoquatam. Cyproterone acetate The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Cyproterone acetate. Desogestrel The therapeutic efficacy of Ox bile extract can be decreased when used in combination with Desogestrel. 
Identify potential medication risksEasily compare up to 40 drugs with our drug interaction checker.Get severity rating, description, and management advice.Learn more - Food Interactions
- Take after a meal.
Products
Drug product information from 10+ global regionsOur datasets provide approved product information including:dosage, form, labeller, route of administration, and marketing period.Access drug product information from over 10 global regions.- Mixture Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Alka-pan Tablets Ox bile extract (35 mg) + Betaine hydrochloride (20 mg) + Bromelains (50 mg) + Pancrelipase (135 mg) + Papaya (125 mg) Tablet Oral Morter Healthsystem Not applicable Not applicable Canada 
Dygest Ox bile extract (75 mg) + Betaine hydrochloride (90 mg) + Pancrelipase (200 mg) + Papain (100 mg) + Peppermint (50 mg) + Pepsin (125 mg) Tablet Oral Creative Nutrition Canada Corp. 1987-12-31 2007-07-11 Canada Enzyme Tablets Ox bile extract (8.125 mg) + Betaine hydrochloride (65 mg) + Pancrelipase (100 mg) + Pancrelipase amylase (130 mg) + Papain (65 mg) + Pepsin (65 mg) Tablet Oral General Nutrition Canada Inc. 2001-10-20 2007-08-01 Canada FLATOL® Ox bile extract (25 mg) + Aspergillus niger var. niger (50 mg) + Pancrelipase (175 mg) + Simethicone (40 mg) Tablet, coated Oral FABRIFARMA S.A. 2018-04-23 Not applicable Colombia 
FLATON ENTERIK DRAJE, 30 ADET Ox bile extract (25 mg) + Hemicellulase (50 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg) Tablet, coated Oral BİLİM İLAÇ SAN. VE TİC. A.Ş. 2020-08-14 Not applicable Turkey 
FLATON ENTERIK DRAJE, 60 ADET Ox bile extract (25 mg) + Hemicellulase (50 mg) + Pancrelipase amylase (3150 FIP) + Pancrelipase lipase (1050 FIP) + Pancrelipase protease (210 FIP) + Simethicone (50 mg) Tablet, coated Oral BİLİM İLAÇ SAN. VE TİC. A.Ş. 2020-08-14 Not applicable Turkey Formule 1705 - Liq Ox bile extract (1.56 mg / mL) + Magnesium sulfate (250 mg / mL) Liquid Oral Bio Vita 1993-12-31 2003-07-16 Canada INTESTAL ENTERIK KAPLI ,120 DRAJE Ox bile extract (21.3 mg) + Activated charcoal (71.1 mg) + Pancrelipase (59.4 mg) Tablet, coated Oral FARMAKO ECZACILIK A.Ş. 2020-08-14 Not applicable Turkey INTESTAL ENTERIK KAPLI DRAJE Ox bile extract (21.3 mg) + Activated charcoal (71.1 mg) + Pancrelipase (59.4 mg) Tablet, coated Oral FARMAKO ECZACILIK A.Ş. 2020-08-14 Not applicable Turkey INTESTINOL DRAJE, 120 ADET Ox bile extract (21.3 mg) + Activated charcoal (71.7 mg) + Pancrelipase (59.4 mg) Tablet, coated Oral KOÇAK FARMA İLAÇ VE KİMYA SAN. A.Ş. 2020-08-14 Not applicable Turkey - Unapproved/Other Products
Name Ingredients Dosage Route Labeller Marketing Start Marketing End Region Image Stozyme Ox bile extract (5.21 1/1001) + Dimethicone (5.21 1/1001) + Hemicellulase (10.42 1/1001) + Pancrelipase (36.46 1/1001) Tablet Oral Chunwoo Pharmaceutical Co., Ltd. 2019-10-19 Not applicable US 
Categories
- Drug Categories
- Classification
- Not classified
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- ET3651ZLOU
- CAS number
- Not Available
References
- General References
- Not Available
- External Links
Clinical Trials
- Clinical Trials
Phase Status Purpose Conditions Count 2 Completed Treatment BMI >27 kg/m2 / Obese / Type 2 Diabetes Mellitus 1
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
Form Route Strength Tablet, coated Oral Liquid Oral Tablet Oral - Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
Drug created at April 25, 2018 22:43 / Updated at September 28, 2021 21:54